For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Published 2008-12-01 00:00:00
This page contains additional content about the article Alendronate with cholecalciferol (vitamin D3) (Fosamax Plus) for osteoporosis, first published in NPS RADAR in August 2006, and last updated in December 2008.
Vitamin D plays a role in calcium homeostasis, which is regulated by parathyroid hormone.
Cholecalciferol (vitamin D3) is obtained from the diet and produced by the action of sunlight on skin. Vitamin D2 and D3 are hydroxylated in the liver to hydroxyvitamin D (25-OHD), the main circulating metabolite. 25-OHD is further hydroxylated in the kidneys to 1,25-dihydroxyvitamin D (1,25-OH2D), or calcitriol, the active form.1
While severe vitamin D deficiency manifests clinically, mild to moderate deficiency may not be obvious. Serum 25-hydroxyvitamin D (25-OHD) levels are the best indicator of vitamin D status and should be maintained at 50 nmol/L or more to prevent and treat osteoporosis in older people.2 Note that optimal levels of serum 25-OHD are not universally agreed.3,4
Deficiency is very common in institutionalised, bed-bound or housebound elderly people (50–80%5,6). Other risk factors for vitamin D deficiency include7:
Adequate vitamin D intake depends primarily on sun exposure, with a minor dietary contribution; recommendations describe 'adequate intake' rather than 'dietary intake', as for other nutrients. The adequate intakes shown in Box 1 assume no sun exposure. Some guidelines suggest higher supplements of at least 800 units for people with inadequate sunlight exposure8,9; and in some cases up to 2000 units per day might be necessary to prevent deficiency (e.g. institutionalised people with reduced food intake).2,8
Patients who are already vitamin D deficient need a vitamin D dosage greater than the adequate intake to replenish depleted stores. Note that vitamin D requirements for people with osteoporosis or those taking anti-resorptive therapy have not been adequately determined.
|
Daily intake |
||
|---|---|---|
|
Age (years) |
Units |
Micrograms |
|
19–50 |
200 |
5 |
*Requirements assuming nil intake through sunlight
Sunlight exposure
For more information on sunlight exposure and vitamin D see Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005;182:281–5.
Dietary sources of vitamin D
Vitamin D supplements
Types of vitamin D supplement available in Australia are shown in Box 2.
|
Cholecalciferol
Ergocalciferol
Calcitriol
|
Date published: 2008-12-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.